التفاصيل البيبلوغرافية
| العنوان: |
512 Understanding Expanded Access: Who are the Patients? |
| المؤلفون: |
Gravelin, Misty, Adamo, Joan E, Ellison, Sharon, Segear, Erika, Parrish, Amanda, Deeter, Christine, Hamill, Jennifer, Soliz, Erik, Idris, Ahamed, Mashour, George A, Weatherwax, Kevin J, Rigan, Laurie |
| المصدر: |
Journal of Clinical & Translational Science; 2024 Suppl 1, Vol. 8, p152-152, 1p |
| مستخلص: |
This document is an abstract from the Journal of Clinical & Translational Science. The abstract discusses various topics related to expanded access to investigational drugs and clinical trials. It includes information on the symptoms and outcome measures important to patients with Huntington's disease, the use of the Unified Huntington's Disease Rating Scale (UHDRS) as a common assessment tool, and the demographics and medical conditions of patients receiving expanded access treatments. Additionally, the abstract mentions a pilot program at Mayo Clinic called the Rapid Activation Trial (RAT) program, which aims to expedite the activation of high priority clinical trials. [Extracted from the article] |
|
Copyright of Journal of Clinical & Translational Science is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder